Obesity Trial, Recruiting NCT04917601 Sponsor: Karolinska Institutet Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT04917601
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children and young people who are older than 4 years and younger than 17 years old at the time of joining
  • Those whose body weight falls within a specific obesity range (based on international guidelines, with a standardised BMI score between 30 and 40) — not severely obese
  • Those whose family is willing to take part in an obesity treatment clinical trial
  • Families who are able to read and write in the language of the country where they live, as the trial uses a mobile phone app with written messages
  • Families where at least one parent has a smartphone and an email address

Who may not be able to join:

  • Those with very severe obesity (a standardised BMI score above 40, regardless of age)
  • Those with hormone-related conditions (such as thyroid problems that are not well controlled, or other hormonal disorders)
  • Those with certain metabolic conditions that affect weight control (confirm with trial site)
  • Those who have been treated for depression or other mental health conditions in the six months before joining
  • Those currently taking any medication known to affect body weight
  • Those whose obesity is caused by a brain-related condition or a genetic syndrome (for example, Down syndrome)
  • Those with serious mental or neurological conditions that could make it difficult to follow the trial requirements
  • Those who have had a diagnosed eating disorder requiring treatment in the six months before joining, or where an eating disorder is identified during the initial screening

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pernilla Danielsson, PhD, Karolinska Institutet

Phone: +46 708 377734

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
24 May 2022
Est. completion
1 December 2027

Where this trial is recruiting

🇮🇹 Italy 🇳🇴 Norway 🇵🇱 Poland 🇸🇪 Sweden

Primary endpoints

Change in degree of obesity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov